Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO).

Autor: Aapro M; Oncology Department, Genolier Cancer Center, Clinique de Genolier, Genolier, Switzerland. Electronic address: maapro@genolier.net., Caprariu Z; Oncomed, Timisoara, Romania., Chilingirov P; Complex Oncology Center, Stara Zagora, Stara Zagora, Bulgaria., Chrápavá M; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic., Curca RO; Emergency County Hospital, Alba Iulia, Romania., Gales L; Department of Medical Oncology, Clinical Hospital for Nephrology 'Carol Davila' Bucharest, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Grigorescu AC; Department of Medical Oncology, Clinical Hospital for Nephrology 'Carol Davila' Bucharest, Bucharest, Romania., Huszno J; Radiotherapy Department, Genetic Outpatient Clinic, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Karlínová B; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic., Kellnerová R; Medical Department, Angelini Pharma, Česká republika s.r.o., Brno, Czech Republic., Malejčíková M; Clinical Oncology Department, National Cancer Institute, Bratislava, Slovak Republic., Marinca M; Grigore T. Popa University of Medicine and Pharmacy, Regional Oncology Institute, Iasi, Romania., Petru E; Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria., Płużanski A; Lung Cancer and Chest Tumors Department, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland., Pokorná P; Department of Oncology, 2(nd) Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic., Pribulova Z; Department of Oncology, East Slovakian Institute of Oncology, Košice, Slovak Republic., Rubach M; Chemotherapy Day Ward, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland., Steger GG; Division of Oncology, Department of Internal Medicine I and Gaston H. Glock - Research Center, Medical University of Vienna, Vienna, Austria., Tesařová P; Department of Oncology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Valekova L; University Hospital Martin, Martin, Slovak Republic., Yordanov N; Department Medical Oncology, Medical University - Sofia, Affiliation - Vratsa, Comprehensive Cancer Center - Vratsa, Vratsa, Bulgaria., Walaszkowska-Czyz A; Szpital Świętej Rodziny, Oddział Onkologiczny, Warsaw, Poland.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 May; Vol. 166, pp. 126-133. Date of Electronic Publication: 2022 Mar 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.

Autor: Minarik, Jiri¹ (AUTHOR) abretina@email.cz, Radocha, Jakub² (AUTHOR), Jungova, Alexandra³ (AUTHOR), Straub, Jan⁴ (AUTHOR), Jelinek, Tomas⁵ (AUTHOR), Pika, Tomas¹ (AUTHOR), Pour, Ludek⁶ (AUTHOR), Pavlicek, Petr⁷ (AUTHOR), Harvanova, Lubica⁸ (AUTHOR), Pospisilova, Lenka⁹ (AUTHOR), Krhovska, Petra¹ (AUTHOR), Novakova, Denisa² (AUTHOR), Jindra, Pavel³ (AUTHOR), Spicka, Ivan⁴ (AUTHOR), Plonkova, Hana⁵ (AUTHOR), Stork, Martin⁶ (AUTHOR), Bacovsky, Jaroslav¹ (AUTHOR), Maisnar, Vladimir² (AUTHOR), Hajek, Roman⁵ (AUTHOR)

Publikováno v: Cancers. Oct2022, Vol. 14 Issue 20, p5165-N.PAG. 13p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.